Cancer Biology

Crown Bioscience's deep expertise in oncology defines the biological basis for the differences between normal and cancer cells. Crown's commitment to the development of predictive in vitro and in vivo research models helps to reveal processes and molecular targets with the potential for therapeutic or preventive intervention. Our comprehensive services for drug development from target to pre-IND have accelerated confident Go/No Go decisions during early stage drug discovery and ensured robust pre-clinical candidate selection.

If your early stage drug development program could benefit from our proprietary platforms with proven predictive power, please call us today! Simply click below to learn more about our service expertise or to get a project budget for your ideas.

>> Cell biology